Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001104659-25-002120
Filing Date
2025-01-10
Accepted
2025-01-08 17:50:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 14D9 tm252270-1_sc14d9.htm SC 14D9 679033
2 GRAPHIC lg_barclays-4c.jpg GRAPHIC 11241
  Complete submission text file 0001104659-25-002120.txt   696654
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filed by) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Subject) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-88269 | Film No.: 25519511
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)